Related Experiment Video
Updated: Dec 22, 2025
09:29
Technique of Subnormothermic Ex Vivo Liver Perfusion for the Storage, Assessment, and Repair of Marginal Liver Grafts
Published on: August 13, 2014
15.5K
Restoring Mitochondrial Function While Avoiding Redox Stress: The Key to Preventing Ischemia/Reperfusion Injury in
Julia Hofmann1, Giorgi Otarashvili1, Andras Meszaros1
1Department of Visceral, Transplant and Thoracic Surgery (VTT), Daniel Swarovski Research Laboratory (DSL), Medical University of Innsbruck (MUI), Innrain 66, A-6020 Innsbruck, Austria.
International Journal of Molecular Sciences
|May 6, 2020
Summary
Mitochondrial reactive oxygen species (ROS) drive ischemia-reperfusion injury (IRI) after transplantation. Understanding mitochondrial dysfunction during machine perfusion may prevent ROS-initiated damage, improving organ survival.
Area of Science:
- Organ transplantation
- Mitochondrial biology
- Ischemia-Reperfusion Injury (IRI)
Background:
- Mitochondria detect organ changes during ischemia and reperfusion.
- Reactive oxygen species (ROS) production by mitochondria initiates ischemia-reperfusion injury (IRI).
- IRI negatively impacts graft function and survival post-transplantation.
Purpose of the Study:
- To explore the molecular mechanisms of IRI during ex vivo machine perfusion.
- To understand how mitochondrial dysfunction contributes to IRI.
- To identify novel strategies for preventing ROS-initiated damage in transplantation.
Main Methods:
- Review of molecular events during machine perfusion.
- Discussion of key mechanisms like succinate accumulation and ATP depletion.
- Analysis of mitochondrial dysfunction in IRI pathogenesis.
Main Results:
- IRI development is initiated by mitochondrial ROS production.
- Ex vivo machine perfusion offers potential to mitigate IRI, especially for extended criteria donor organs.
- The precise molecular events during machine perfusion require further elucidation.
Conclusions:
- Understanding mitochondrial dysfunction in IRI is crucial for developing new prevention strategies.
- Targeting ROS-initiated damage is key in the era of machine perfusion.
- Further research into machine perfusion's molecular effects can enhance organ transplantation outcomes.
